| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |